GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

NCT00707031 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

639

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Lixisenatide (AVE0010)
DEVICE: Pen auto-injector
DRUG: Exenatide
DEVICE: Prefilled pen injector
DRUG: Metformin

Sponsor

Sanofi